To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:10 Issue:2 Number:36 ISSN#:2564-2537
RCT
ACE Report #13116
Ace Report Cover Arthroplasty

100 mg Aspirin Twice Daily Non-Inferior to Once Daily 10 mg Rivaroxaban for Prevention of VTE in THA


How to Cite

OrthoEvidence. 100 mg Aspirin Twice Daily Non-Inferior to Once Daily 10 mg Rivaroxaban for Prevention of VTE in THA. ACE Report. 2021;10(2):36. Available from: https://myorthoevidence.com/AceReport/Report/13116

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial

Chin Med J (Engl). 2021 Jan 5;134(2):164-172.

Contributing Authors: Y Ren SL Cao Z Li T Luo B Feng XS Weng

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventy-eight patients undergoing a unilateral total hip arthroplasty (THA) were randomized in this non-inferiority trial to receive 5 weeks of aspirin (100 mg twice per day; n=37) or 5 weeks of rivaroxaban (10 mg once per day) post-operation for the prevention of deep vein thrombosis (DVT). The primary outcome of interest was the incidence of DVT which was assessed using Doppler ultrasonography a...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.